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Abstract Participation rates in cancer genetic counseling dif-
fer among populations, as patients with a lower educational
background and migrant patients seem to have poorer access
to it. We conducted a study to determine the present-day edu-
cational level and migrant status of counselees referred to
cancer genetic counseling. We assessed personal characteris-
tics and demographics of 731 newly referred counselees.
Descriptive statistics were used to describe these characteris-
tics. The results show that about 40% of the counselees had a
high educational level and 89% were Dutch natives.
Compared to the Dutch population, we found a significant
difference in educational level (p = < 0.01) and migrant status
(p = < 0.001). This suggests disparities in cancer genetic
counseling and as a result of that, suboptimal care for vulner-
able groups. Limited health literacy is likely to pose a partic-
ular challenge to cancer genetic counseling for counselees
with a lower education or a migrant background. Our study
points to considerable scope for improvement in referring vul-
nerable groups of patients for cancer genetic counseling.
Keywords Cancer genetic counseling . Referral . Migrant
status . Educational level
Introduction
For families in which a hereditary form of cancer is suspected,
cancer genetic counseling can add to the optimal treatment
and clinical management of patients. It can serve as a valuable
aid for surveillance and/or preventive surgery for patients af-
fected by cancer and their unaffected family members.
Therefore, identifying patients eligible for cancer genetic
counseling and referring them is important. Unfortunately,
due to various physician- and patient-related factors (Brandt
et al. 2008), not all patients eligible for genetic counseling are
recognized by their physicians (Kurian et al. 2017).
Physician-related factors
From physicians’ perspective, patient eligibility for cancer
genetic counseling is based on family history, patient cancer
history, and patient request (Brandt et al. 2008). The first chal-
lenge for physicians is to identify patients eligible for referral
by gathering adequate information about the family history.
As shown, EMRs (electronic medical records) do not always
contain enough information about family history (Sollie et al.
2016; Vogel et al. 2012). Vogel et al. (2012) found that only
50% of the patients who are eligible for referral for Lynch
syndrome and hereditary breast and ovarian cancer could be
identified by the EMR. Current standard clinical practices
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seem insufficient at identifying patients who meet the criteria
for referral to genetic counseling.
The majority of physicians experience a lack of time to
collect detailed information about family history (Al-Habsi
et al. 2008; Wood et al. 2008). Insufficient knowledge about
hereditary cancer and about the criteria for referral acts as
another barrier for referral (Dekker et al. 2013; Panic et al.
2014). Besides, physicians tend to overestimate the risk of
patients who actually are at population risk, while
underestimating risk of patients who are at increased risk of
developing cancer (Baldwin et al. 2014). Despite the fact that
referral guidelines are sufficiently available, numerous studies
have shown that physicians are still lacking knowledge of
genetics and the latest criteria for referral (Douma et al.
2016; Prochniak et al. 2012).
When physicians are convinced, there is a high probability
that the risk is hereditary; they have a tendency to refer pa-
tients for periodic screening examinations instead of genetic
counseling (Burke et al. 2009; Sollie et al. 2016). For colorec-
tal cancer syndromes, Prochniak et al. (2012) found that, al-
though physicians endorsed guidelines as a significant influ-
ence on their practice decisions, these guidelines did not in-
fluence the referral to cancer genetic counseling. The low
adherence to guidelines for referral and poor registration of
family history may also be responsible for the differences in
referral to cancer genetic counseling in migrant patients. In a
study among Turkish and Moroccan patients by Baars et al.
(2016), the lowest referral rates are observed in the group of
women with breast cancer at young age, despite the fact that
age < 40 years is a criterion for referral, independent of family
history and migrant status (Baars et al. 2016).
Patient-related factors
Patient characteristics influence the referral process as
well. Patients’ request for cancer genetic counseling
and their concerns about family members are important
determinants for cancer genetic counseling. Van Riel
et al. (2012) showed that the majority of counselees
initiate a referral themselves (van Riel et al. 2012),
while Brandt et al. (2008) found that 73% of a group
of primary care physicians and specialists base patient
eligibility for referral on patient request, and 54% did
not refer eligible patients due to patient disinterest.
When physicians are not sure whether screening is rec-
ommended, patients who expect screening and those
who are more anxious, are more often referred
(Haggerty et al. 2005). Apparently, cancer-related con-
cerns, but also perceived cancer risk and the belief that
family history influences cancer risk, contribute to refer-
ral for cancer genetic counseling (Bellcross et al. 2015).
Lack of awareness and/or knowledge about personal risk,
medical history, and genetic services, seem to act as barriers to
referral to cancer genetic counseling (Delikurt et al. 2015).
Research from Allford et al. (2014) suggests low awareness
and understanding of familial cancer risk among minority eth-
nic communities (Allford et al. 2014). Also, socio-cultural
variations in beliefs, notably stigma about cancer of inherited
risk of cancer, have been identified. For migrant breast cancer
patients, language difficulties and lower health literacy, as
well as cultural factors, are determinants for non-
participation in genetic counseling (Baars et al. 2017).
Sharing information with the physician about family histo-
ry in relation to cancer, is an important factor in the referral
process. Patients with a lower social economic status, a lower
educational background, or a migrant background, experience
greater verbal passivity and difficulties in presenting health-
related information to their physician (Cooper and Roter,
2003).
Differences in cancer incidence
Cancer incidence may vary in the population and therefore re-
sult in different participation rates in cancer genetic counseling.
Migrants and people of low socioeconomic status (SES) share
certain cancer risks, like the lower risks for colon, skin, breast,
and prostate cancer (Aarts et al. 2010; Arnold et al. 2010). Non-
western migrants exhibit a higher burden of infection-related
tumors (Arnold et al. 2010; Dutch Cancer Society 2006;
Visser and van Leeuwen, 2007). The difference in cancer inci-
dence in the population is complex, because higher cancer
awareness and participation in cancer screening programs,
might have contributed to a higher incidence for certain types
of cancer, like breast cancer. This is usually promoted more by
patients of high SES (Aarts et al. 2010). Recent research from
Welch and Fisher (2017) confirms that cancer screening is one
area in which overutilization can result in overdiagnosis, partic-
ularly for cancers for which the reported incidence is sensitive to
early screening programs (Welch and Fisher, 2017). Reported
higher incidence does not seem to lead to a parallel increase in
prevalence, as shown by the database from the National Institute
of Public Health and the Environment (RIVM). This database
showed no significant difference in prevalence of cancer be-
tween the lowest and highest educated people (National
Institute for Public Health and the Environment 2012).
Cancer genetic counseling
In order to gain more insight in factors associated with referral
to genetic counseling, we conducted an observational study in
2007 (van Riel et al. 2012). That study showed that, compared
to the general population, more highly educated counselees
and less migrant counselees were seen in cancer genetic
counseling practice.
Since 2007, more information has become available about
hereditary cancer and referral for cancer genetic counseling.
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For physicians, guidelines have been updated and published
about criteria for referral (Balmana et al. 2013; Berliner et al.
2013; Giardiello et al. 2014). Also, additional value of inter-
ventions, such as an online referral test, an interactive web-
based training and an electronic referral form, has been report-
ed (Bell et al. 2015; Dekker et al. 2014; Petzel et al. 2014).
For the general public, attention to this subject has been
drawn in the media, e.g., by the release of a public statement
Table 1 General characteristics of 731 counselees requesting cancer genetic counseling
Variable Both clinics combined %
(n = 731)
University hospital %
(n = 403)a
Community hospitals %
(n = 328)a
p
value
Total 100.0 55.1 44.9
Gender Male 25.6 (187) 26.6 (107) 24.4 (80) n.s.
Female 74.4 (544) 73.4 (296) 75.6 (248)
Personal cancer history Affected 50.8 (371) 46.7 (188) 55.8 (183) 0.014*
Unaffected 49.2 (360) 53.3 (215) 44.2 (145)
Affected with (n = 371) Breast cancer 56.3 (209) 60.6 (114) 51.9 (95) n.s.
Ovarian cancer 4.0 (15) 2.7 (5) 5.5 (10) n.s.
Colon cancer 16.4 (61) 10.1 (19) 23.0 (42) 0.001*
Endometrial cancer 0.8 (3) 1.6 (3) 0 (0) n.s.
Melanoma 2.7 (10) 4.3 (8) 1.1 (2) n.s.
Polyposis 9.2 (34) 9.6 (18) 8.7 (16) n.s.
≥ 2 kinds of cancer 5.1 (19) 5.3 (10) 4.9 (9) n.s.
Otherb 5.4 (20) 5.9 (11) 4.9 (9) n.s.
Eligibility for genetic testing in
counselee or relative
Diagnostic DNA
testing
38.2 (279) 36.0 (145) 40.9 (134) n.s.
MSI/IHCc 11.6 (85) 9.4 (38) 14.3 (47) 0.040*
Predictive testingd 22.0 (161) 29.5 (119) 12.8 (42) 0.000*
Did not meet criteria
for testing
10.4 (76) 8.7 (35) 12.5 (41) n.s.
Other 17.8 (130) 16.4 (66) 19.5 (64) n.s.
Initiator discussing family history Counselee 35.6 (252) 38.3 (148) 32.4 (104) n.s.
(n = 707) Physician 48.4 (342) 42.2 (163) 55.8 (179) 0.000*
Other 16.0 (113) 19.4 (75) 11.8 (38) 0.006*
Educational levele (n = 714) Low 5.0 (36) 4.1 (16) 6.2 (20) n.s.
Intermediate-1 21.6 (154) 18.7 (73) 25.1 (81) 0.038*
Intermediate-2 35.2 (251) 31.7 (124) 39.3 (127) 0.034*
High 38.2 (273) 45.5 (178) 29.4 (95) 0.000*
Migrant statusf (n = 723) Dutch native 88.7 (641) 86.6 (342) 91.2 (299) 0.053*
Migrant 11.3 (82) 13.4 (53) 8.8 (29)
Migrant, western 6.7 (49) 7.1 (28) 6.4 (21) n.s.
Migrant, non-western 4.6 (33) 6.3 (25) 2.4 (8) 0.013*
*A two-sided p value of < 0.05 is considered significant. n.s.: not significant
a Data calculated for clinical setting (i.e., within each column)
bOther cancer: parathyroid adenoma, angiolipoma, carcinoid, brain tumor, hyperparathyroidism, pituitary tumor, leiomyomatosis, leukemia, neurofi-
broma, kidney cancer, pancreatic cancer, prostate cancer, sarcoma, sebaceoma, esophageal cancer, and testis carcinoma
cMSI/IHC: microsatellite instability testing/immunohistochemistry for mismatch repair deficiency
d Predictive testing: genetic testing for a mutation which is already known in the family of the counselee
e Low: (pre-)primary education or first stage of basic education; Intermediate-1: lower secondary or second stage of basic education; Intermediate-2:
(upper) secondary education; High: tertiary education
f Dutch native: both parents are born in The Netherlands; Migrant: at least one of the parents is born outside the Netherlands. Western Migrant: at least
one parent born outside the Netherlands, but in Europe, North America, Australia, New Zealand, Indonesia, and Japan; Non-Western Migrant: at least
one parent born in Turkey and countries in Africa, Latin America, and Asian countries
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from actress Angelina Jolie (Evans et al. 2014; Roberts and
Dusetzina, 2017).
Over the years, for both physicians as the general popula-
tion, awareness about cancer genetic counseling has in-
creased. This is expected to be reflected in a cancer genetic
counseling population which is more comparable to the gen-
eral population when it comes to educational level and mi-
grant status. To study this expectation, we conducted a study,
8 years after our previous study, with the aim to determine the
present-day educational level and migrant status of counselees
referred to cancer genetic counseling and to investigate possi-
ble differences with our 2007 data.
Methods
Participants
Participants were newly referred counselees for cancer genetic
counseling from October 2014 to April 2015. Similar to our
previous study (van Riel et al. 2012), counselees were seen by
a clinical geneticist or genetic counselor from the department
of Genetics of the University Medical Center Utrecht at either
the university main site or one of the nine community hospi-
tals in the region.
Study design and data collection
For each new counselee, a checklist was filled in by the coun-
selor during the first consultation. In this checklist, several
items were scored: general characteristics of the counselee
and the consultation, eligibility for genetic testing, educational
level, country of birth of counselee and his/her parents (see
Electronic Supplementary Material).
Educational level was determined by the Dutch Standard
Classification of Education (Statistics Netherlands 2008) and
the international classification of the UNESCO (Unesco
Institute for Statistics 2011): low educational level: (pre-)pri-
mary education or first stage of basic education; intermediate-
1 educational level: lower secondary or second stage of basic
education; intermediate-2 educational level: (upper) second-
ary education; and high educational level: tertiary education.
Migrant status of the counselee was determined according
to the definition of Statistics Netherlands (Statistics
Netherlands 2008). According to this definition, a counselee
is a migrant when at least one of the parents is born outside of
the Netherlands. Furthermore, a distinction can be made be-
tween Western migrants (at least one parent born outside the
Netherlands, but in Europe, North America, Australia, New
Zealand, Indonesia, and Japan) and non-Western migrants (at
least one parent born in Turkey and countries in Africa, Latin
America, and Asian countries). The classifications of
Table 2 Educational level and
migrant status of counselees in
cancer genetic counseling in
comparison to the general
population in the Netherlands
This study (2014/2015) % (n) General population (2014) % (n) p value
Educational level
Low 5.0 (36) 9.8 (1,229,000) < 0.01
Intermediate-1 21.6 (154) 21.0 (2,625,000) 0.7033
Intermediate-2 35.2 (251) 40.7 (508,900) < 0.01
High 38.2 (273) 28.5 (3,564,000) < 0.01
Migrant status
Dutch native 88.7 (641) 78.6 (13,234,545) < 0.001
Migrant 11.3 (82) 21.4 (3,594,744)
- Western 6.8 (49) 9.5 (1,597,160)
- non-Western 4.6 (33) 11.9 (1,997,584)
Table 3 Educational level and
migrant status of counselees in
cancer genetic counseling in
comparison to the study in 2007
(Van Riel et al. 2012)
This study (2014/2015) % (n) Study data (2007) % (n) p value
Educational level
Low 5.0 (36) 4.0 (16) 0.4340
Intermediate-1 21.6 (154) 26.3 (105) 0.0723
Intermediate-2 35.2 (251) 33.3 (133) 0.5400
High 38.2 (273) 36.3 (145) 0.5314
Migrant status
Dutch native 88.7 (641) 90.6 (368) 0.2998
Migrant 11.3 (82) 9.4 (38)
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educational level and migrant status of Statistics Netherlands
was chosen to allow comparison with data about the general
population of the Netherlands. Also, these same classifications
were used in our earlier study (van Riel et al. 2012), so, com-
parison with the data of the current study with the situation in
2007 is possible.
Eligibility for genetic testing was determined for the coun-
selee or for an affected family member of the counselee based
on family history and/or (if available at initial consultation)
medical records, according to national guidelines for different
tumor syndromes used in daily practice.
The subgroup Bother^ in eligibility for genetic testing con-
tains several reasons, e.g., eligibility can be determined after
receiving the medical records of the counselee and/or family
members, which are not always present at first consultation.
Also, in initiating discussion of family history, a category
Bother^ exists. This category contains initiating discussion of
family history by a family member, by a family letter (a letter
in case a mutation in a cancer gene is detected, intended to
share with family), by the counselee and physician together, or
by the physician of a family member.
Statistical analysis
All data were entered in SPSS Version 21.0.0. Descriptive
statistics were used to describe counselee characteristics, for
university and community hospitals separately, and for both
clinics combined. Chi-square tests were used to compare the
collected data to the data of the general population in the
Netherlands (Statistics Netherlands 2014a; Statistics
Netherlands 2014b).
Results
General characteristics
In total, 731 counselees were included. General characteris-
tics, like clinical setting of the consultation, gender and per-
sonal cancer history of the counselee, and eligibility for genet-
ic testing are shown in Table 1. There were more female coun-
selees compared to male counselees, as more than half (56%)
of the affected counselees had breast cancer. About half of all
counselees were seen in the university hospital (55%); the
other 45%were seen in community hospitals. This is the same
distribution as reported earlier in our study in 2007 (van Riel
et al. 2012).
When we compare the referral between university hospital
and community hospitals, we found that more counselees af-
fected with colon cancer were seen in community hospitals,
which explains the higher eligibility for microsatellite insta-
bility testing/immune histochemistry (MSI/IHC) of coun-
selees seen in community hospitals. In the university hospital,
more counselees were seen for predictive testing for a known
mutation.
In initiating discussion of family history, we found discus-
sion started by a family member in 58%, by a family letter in
23%, by the counselee and physician together in 14%, and by
the physician of a family member in 5%. In community hos-
pitals, the physician more often initiated discussion of family
history, and less often, this discussion is initiated by Bother^
(e.g., a family member or via a family letter).
Educational level
When classified according to the International Standard
Classification of Education (Unesco Institute for Statistics
2011), about 40% of the counselees seen for cancer genetic
counseling had a high educational level. When compared for
clinical setting, more counselees with an intermediate-1 and
intermediate-2 level of education were seen in community
hospitals, and more highly educated counselees were seen in
the university hospital. In comparison with the Dutch popula-
tion (Table 2), less counselees with a lower and intermediate-2
educational level and more highly educated counselees were
seen in cancer genetic counseling. No significant difference
was found in the educational level of counselees in 2007 and
in 2014/2015 (van Riel et al. 2012) (Table 3).
Migrant status
The majority of counselees seen for cancer genetic counseling
were Dutch natives (89%). There is a trend for less migrants
seen in the community hospitals (p = 0.05). When migrants of
Western and non-Western origin were compared, a signifi-
cantly lower percentage of non-Western migrants is seen in
community hospitals than in the university hospital.
Furthermore, there were less migrants seen in cancer genetic
counseling compared to the general population (Table 2)
(p < 0.001). We found no significant difference in frequency
of migrants referred for cancer genetic counseling 2014/2015
and 2007 (van Riel et al. 2012), (Table 3).
Discussion
Our findings suggest that patients’ migrant status and educa-
tional background seem to matter in the referral to cancer
genetic counseling. In 2007, we found an underrepresentation
in cancer genetic counseling of migrant patients and patients
with a low educational background (van Riel et al. 2012). The
results of the current study show that this underrepresentation
has not changed since then. This differential access to cancer
genetic counseling may lead to treatment and outcome dispar-
ities in cancer care.
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The differences in educational level and migrant status, seen
between counselees in the university hospital and counselees
seen in the community hospital, must be taken into account.
However, definite conclusions cannot be drawn from these data
because of potential differences in the patient population at the
different locations. Socio demographic characteristics may have
impact on patients’ communicative behavior (e.g., asking ques-
tions or expressing concerns) as well on physicians’ behavior
(discussing referral possibility) (Baars et al. 2017).
In the last years, more information about cancer genetics
and genetic counseling has become accessible to the general
public. From popular magazines, there is an increasing focus
on hereditary cancer and referral for DNA-testing. This may
affect people’s awareness for cancer genetic counseling and
may even contribute to more patient request. As we know,
patients’ initiative is important in the referral process (Brandt
et al. 2008; Wideroff et al. 2003). Asking questions about
genetic testing increases the likelihood of being referred for
genetic counseling (Al-Habsi et al. 2008; Klitzman et al.
2013). This might be an explanation for the relatively low
attendance of migrant patients and patients with a lower edu-
cational background. Asking questions is associated with
someone’s health literacy skills (Katz et al. 2007). Health lit-
eracy skills reflect the ability to access, understand, appraise,
and use health-related information in various domains
(Sorensen et al. 2012) and are associated with lower patient
activation (Smith et al. 2013). People with a lower socio-
economic position, a lower educational level, and a lower
subjective social status, are known to have lower health liter-
acy skills than those with a high socio-economic position
(Heide van der et al. 2013). Also, many migrant patients have
lower health literacy skills (Fransen et al. 2013). This might
result in low awareness or understanding of familial cancer. In
combination with socio-cultural variations in beliefs about
cancer, this may affect patient-doctor communication, as well
as referral to cancer genetic counseling (Baars et al. 2017).
Given the fact that the majority of counselees seem to initiate
referral to genetic counseling themselves (Brandt et al. 2008;
van Riel et al. 2012), lower health literacy and corresponding
lower patient activation, might contribute to the lower referral
rate in migrant patients and in patients with a lower level of
education. Physicians will have to adapt their communication
to this group of patients in order to allow effective communi-
cation and get a higher referral rate. Recent research (Kurian
et al. 2017) emphasizes the importance of oncologists’ behav-
ior in the genetic testing process. Improving their communi-
cation skills and risk estimation and optimizing triage to ge-
netic counselors have priority.
Lower educated counselees may have other needs for ge-
netic care than higher educated counselees (Hayat et al. 2012),
who argue for a more personalized approach in both the refer-
ral process and in the genetic counseling itself. Culture-
sensitive interventions can ameliorate referral to cancer
genetic counseling (Hall and Olopade, 2006). Our study
points to room for improvement in referring vulnerable groups
of patients. Since the outcome of cancer genetic counseling
can give reasons to choose another treatment procedure, this is
even more important (Christinat and Pagani, 2013; Glenn
et al. 2012; Wevers et al. 2012). Limited health literacy is
likely to pose a particular challenge to cancer genetic counsel-
ing for counselees with a lower education or a migrant back-
ground. Future studies can explore how physicians should
assess patients’ need and skills and which communication
strategies are effective.
Limitations
Our findings cannot be generalized as the study was conduct-
ed in one single clinical genetic center. However, we included
a rather large number of counselees (over 700 consecutive
counselees seen for cancer genetic counseling) who were seen
in several hospitals in the central region of the Netherlands.
Due to the study design, we do not have data about counselees
who declined referral for cancer genetic counseling. These
possible decliners may have had a different educational back-
ground. Also, we did not measure the level of health literacy
of the patients, but considered educational background as a
proxy (Heide van der et al. 2013; Martin et al. 2009).
Numerous studies show the importance of patient request or
initiative in the referral process. However, in our study, we
found no association between initiative of the counselee and
participation in cancer genetic counseling. That is probably
because of bias in the scoring procedure. Although we asked
who took the initiative for referral, we realize that this out-
come is fairly unreliable. It is not always clear who took the
initiative and sometimes the respondents did not even
remember.
The observed difference in referral between university and
community hospitals might be influenced by the approach of
our genetic clinic: When a pathogenic mutation is identified in
the index case, he/she receives a family letter to inform family
members. With this letter, family members can directly con-
tact our department at the university hospital, and are more
often invited for a consultation at this location. Furthermore,
more information about characteristics of the referring physi-
cians and their practice might lead to a better clarification of
the differences seen between consultations in the different
clinical settings.
As cancer incidence, as well as demographics of the Dutch
population, vary over years, this may influence the referral for
cancer genetic counseling. In our study, we did not standardize
for these differences. Related to migrant status and socioeco-
nomic inequalities, a variety of studies from Europe has
shown that disparities in the burden of cancer exist (Arnold
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et al. 2010). In further research, we must take these differences
into account.
To conclude, the results in this study are similar to the
results in 2007. Lower participation in cancer genetic counsel-
ing by migrant patients and patients with a lower educational
background is still a cause for concern. Additional research on
interventions on how to improve referral for these patients is
urgently desired.
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